PARAVENTRICULAR NUCLEUS AND GENDER IN HYPERTENSION

高血压中的室旁核和性别

基本信息

项目摘要

DESCRIPTION: (Adapted from the Applicant's Abstract) The hypothesis to be tested is that in sodium-dependent hypertension GABAergic inhibition of glutamatergic function in the paraventricular nucleus of the hypothalamus (PVN) is reduced permitting activation of descending pathways to stimulate the sympathetic nervous system. In female rats, glutamatergic activity is reduced in the PVN attenuating the activation of neural pathways responsible for increasing arterial pressure. Three specific aims will be investigated to test this hypothesis. First, the hypothesis that female rats are protected against the development of hypertension because the sympathetic nervous system is not activated will be studied. These studies will determine the level of activity of the sympathoadrenal nervous system using multiple assessments of neural function to define neural activity. The second aim will focus on neurochemical mechanisms in the PVN as a causative factor in the hypertensive process. It is hypothesized that increased stimulation of NMDA glutamatergic receptors occurs as a result of reduced inhibition by GABA. In female rats hypertension is attenuated as a result of a reduced stimulation of the glutamate receptor limiting the increase in arterial pressure. In the third aim, it is hypothesized that Angiotensin II in the PVN facilitates the effect of glutamate in mediating sodium-dependent hypertension. The contribution of Angiotensin II to glutamatergic excitation will be studied in male and female rats to determine if angiotensin determines the difference in sensitivity to glutamate stimulation in males and females. To implement these aims, five groups of animals will be studied: male rats, female rats during basal estrogen levels (diestrous/estrous), female rats during estrogen surge (proestrus), ovariectomized female rats and ovariectomized female rats treated with estradiol and progesterone to mimic the estrous cycle. Arterial pressure will be monitored in conscious one-kidney figure-8 renal wrap hypertensive rats. Pharmacological intervention of the GABA, glutamate and angiotensin II systems in the PVN using microinjections will reveal differences in neurotransmitter function. Microinjection studies will be complemented by receptor autoradiography and microdialysis experiments. Together, the results of this work will provide important new findings into the mechanisms of sodium-dependent hypertension. Importantly, insights into the basis of gender differences in the expression of hypertension will be revealed.
描述:(改编自申请人摘要)假设是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph R Haywood其他文献

Joseph R Haywood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph R Haywood', 18)}}的其他基金

MSU Clinical Center Animal Facility HVAC Upgrade
密歇根州立大学临床中心动物设施 HVAC 升级
  • 批准号:
    8185686
  • 财政年份:
    2012
  • 资助金额:
    $ 21.17万
  • 项目类别:
MSU-Short Course in Integrative Pharmacology
MSU-综合药理学短期课程
  • 批准号:
    6918315
  • 财政年份:
    2005
  • 资助金额:
    $ 21.17万
  • 项目类别:
MSU-Short Course in Integrative Pharmacology
MSU-综合药理学短期课程
  • 批准号:
    7112930
  • 财政年份:
    2005
  • 资助金额:
    $ 21.17万
  • 项目类别:
MSU-Short Course in Integrative Pharmacology
MSU-综合药理学短期课程
  • 批准号:
    7586804
  • 财政年份:
    2005
  • 资助金额:
    $ 21.17万
  • 项目类别:
MSU-Short Course in Integrative Pharmacology
MSU-综合药理学短期课程
  • 批准号:
    7275325
  • 财政年份:
    2005
  • 资助金额:
    $ 21.17万
  • 项目类别:
ANGIOTENSIN, SODIUM AND GENES IN PRIMATE HYPERTENSION
灵长类高血压的血管紧张素、钠和基因
  • 批准号:
    6942050
  • 财政年份:
    2003
  • 资助金额:
    $ 21.17万
  • 项目类别:
Angiotensin, Sodium and Genes in Primate Hypertension
灵长类高血压中的血管紧张素、钠和基因
  • 批准号:
    6662956
  • 财政年份:
    2002
  • 资助金额:
    $ 21.17万
  • 项目类别:
Angiotensin, Sodium and Genes in Primate Hypertension
灵长类高血压中的血管紧张素、钠和基因
  • 批准号:
    6479485
  • 财政年份:
    2002
  • 资助金额:
    $ 21.17万
  • 项目类别:
PARAVENTRICULAR NUCLEUS AND GENDER IN HYPERTENSION
高血压中的室旁核和性别
  • 批准号:
    6183749
  • 财政年份:
    1997
  • 资助金额:
    $ 21.17万
  • 项目类别:
PARAVENTRICULAR NUCLEUS AND GENDER IN HYPERTENSION
高血压中的室旁核和性别
  • 批准号:
    2030192
  • 财政年份:
    1997
  • 资助金额:
    $ 21.17万
  • 项目类别:

相似海外基金

Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
  • 批准号:
    493141
  • 财政年份:
    2023
  • 资助金额:
    $ 21.17万
  • 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
  • 批准号:
    10734120
  • 财政年份:
    2023
  • 资助金额:
    $ 21.17万
  • 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10707997
  • 财政年份:
    2022
  • 资助金额:
    $ 21.17万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2022
  • 资助金额:
    $ 21.17万
  • 项目类别:
    Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10555926
  • 财政年份:
    2022
  • 资助金额:
    $ 21.17万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2021
  • 资助金额:
    $ 21.17万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
  • 批准号:
    445961
  • 财政年份:
    2021
  • 资助金额:
    $ 21.17万
  • 项目类别:
    Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
  • 批准号:
    10164776
  • 财政年份:
    2020
  • 资助金额:
    $ 21.17万
  • 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
  • 批准号:
    10251271
  • 财政年份:
    2020
  • 资助金额:
    $ 21.17万
  • 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
  • 批准号:
    20K09284
  • 财政年份:
    2020
  • 资助金额:
    $ 21.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了